Ea. Healey et al., A 10-YEAR EXPERIENCE OF PEDIATRIC BRACHYTHERAPY, International journal of radiation oncology, biology, physics, 32(2), 1995, pp. 451-455
Citations number
12
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: The purpose of this project was to review the brachytherapy e
xperience in the pediatric population at the Joint Center for Radiatio
n Therapy (JCRT) with respect to efficacy and morbidity. Methods and M
aterials: Treatment outcome was reviewed for 18 children between the a
ges of 6 months and 23 years who received 19 implants between 1982 and
1992 at JCRT. Fourteen children received permanent Iodine-125 seed im
plants placed in the operative tumor bed at the time of resection. Two
children received stereotactically placed afterloaded high-activity I
-125 seed brain implants, and one child received a high-activity I-125
brain implant followed by a permanent I-125 seed brain implant 3 year
s later. One girl received a temporary Iridium-192 volume implant for
a vulvar rhabdomyosarcoma. Among the 15 permanent I-125 implants, the
cases included five primary brain tumors, one metastatic brain tumor,
six sarcomas, and one each of the following: suprarenal neuroblastoma,
hepatoblastoma, and adenocarcinoma of the pancreas. All patients unde
rwent surgery and most patients (15 out of 18) received external beam
radiotherapy to a field that included the implant. Results: The median
follow-up from the time of diagnosis for patients who remain alive is
55 months (range 24 to 119 months), and the median follow-up from the
time of implant is 46 months (15 to 60 months). Disease was controlle
d in the area of the implant in 13 of 17 evaluable cases. Two patients
experienced treatment-related morbidity; one patient developed severe
desquamation related to an ''adriamycin recall reaction,'' and one pa
tient died of postoperative complications. Conclusion: Despite the het
erogeneous mix of cases, the use of brachytherapy in this pediatric po
pulation resulted in several cases of long-term disease control, and t
he overall morbidity was very low. Therefore, in properly selected ped
iatric cases, brachytherapy appears to be an efficacious adjunct to mu
ltimodality cancer management.